Thermodynamic therapy (TDT) based
on oxygen-independent free radicals
exhibits promising potential for the treatment of hypoxic tumors.
However, its therapeutic efficacy is seriously limited by the premature
release of the drug and the free radical scavenging effect of glutathione
(GSH) in tumors. Herein, we report a GSH depletion and biosynthesis
inhibition strategy using EGCG/Fe-camouflaged gold nanorod core/ZIF-8
shell nanoparticles embedded with azo initiator 2,2′-azobis[2-(2-imidazolin-2-yl)
propane] dihydrochloride (AIPH) and L-buthionine-sulfoximine (BSO)
for tumor-targeting photothermal (PTT) and thermodynamic therapy (TDT).
This nanoplatform (GNR@ZIF-8-AIPH/BSO@EGCG/Fe, GZABEF) endows a pH-responsive
release performance. With the 67 kDa lamin receptor (67LR)-targeting
ability of EGCG, GZABEF could selectively release oxygen-independent
free radicals in tumor cells under 1064 nm laser irradiation. More
importantly, Fe3+-mediated GSH depletion and BSO-mediated
GSH biosynthesis inhibition significantly boosted the accumulation
of alkyl radicals. In 4T1 cells, GZABEF induced cancer cell death
via intracellular GSH depletion and GSH peroxidase 4 (GPX4) inactivation.
In a subcutaneous xenograft model of 4T1, GZABEF demonstrated remarkable
tumor growth inhibition (78.2%). In addition, excellent biosafety
and biocompatibility of GZABEF were observed both in vitro and in
vivo. This study provides inspiration for amplified TDT/PTT-mediated
antitumor efficacy.